Tag Archives: efficacy

J&J to stop selling pelvic mesh tied to lawsuits

WASHINGTON (AP) — Johnson & Johnson plans to stop selling surgical mesh implants used to treat women’s health problems, which have been linked to injuries and triggered hundreds of lawsuits.

The company sent a letter Monday to judges in new Jersey and West Virginia who are overseeing patient lawsuits against the company. J&J said it plans to phase out four mesh products over the next three to nine months.

The plastic mesh is used to strengthen the pelvic wall in cases of pelvic organ prolapse, in which the bladder or other reproductive organs slip down into the vagina. about 75,000 women had prolapse surgery with mesh inserted through the vagina last year. A similar procedure using an incision in the abdomen is less common.

J&J said the mesh products are safe and that it is not recalling them.

“Our decision to discontinue these products is based on their commercial viability in light of changing market dynamics, and is not related to safety or efficacy,” the new Brunswick, N.J., company said in a statement.

But the Food and Drug Administration reported last year that the implants were associated with higher rates of pain, bleeding and infection than traditional surgery with stitches. The agency said 10 percent of women experienced erosion or exposure of the mesh within 12 months of having the mesh implanted. more than half of these women required follow-up surgery to remove the mesh. some required two or three surgeries.

At the same time, the FDA said it saw no evidence that using mesh led to better outcomes than traditional surgery with stitches.

In January, the FDA ordered J&J and five other companies to conduct rigorous studies to track the complication rates with their products over time. J&J said in its letter it expects the FDA to waive that requirement once it phases out the products.

Consumer safety advocates hailed the announcement as a victory.

“These companies know they will never be able to prove safety and efficacy of these devices in the studies mandated by the FDA in January of this year,” said Lana Keeton, a Miami resident who has undergone 17 surgeries to remove mesh that was implanted in 2001. Keeton’s group, Truth in Medicine, has lobbied the FDA on the risks of mesh in recent years.

Mesh products initially were seen as a high-tech improvement over traditional surgery, which also can have complications. Since similar mesh was already used in other types of surgery, the products received fast-track approval from the FDA without the tests that the agency requires for first-of-a-kind devices.

In its last quarterly filing with regulators, J&J said the “number of pending product liability lawsuits continues to increase,” and that it has set aside money to pay for litigation costs associated with the mesh, though it didn’t specify an amount.

Federal cases against the company have been consolidated in the Southern District of West Virginia. The state cases in new Jersey have been centralized in a state court in Atlantic County.

Other manufacturers of pelvic mesh include Boston Scientific Corp., Covidien plc, CR Bard Inc. and American Medical Systems.

J&J to stop selling pelvic mesh tied to lawsuits

Pill to Increase Motivation to Exercise

Pill to Increase Motivation to Exercise

A new kind of pill can make a person want to exercise more, a research says.

The researchers say that erythropoietin (Epo) could be used to help people exercise. they found that Epo worked in animal models by increasing motivation to exercise. Also, the hormone did not increase the red blood cell count.

“Here we show that Epo increases the motivation to exercise. most probably, Epo has a general effect on a person’s mood and might be used in patients suffering from depression and related diseases,” said Max Gassmann, researcher from the Institute of Veterinary Physiology, University of Zurich, who was involved in the work.

Previous research said that Epo helps increase exercise capacity in people who’ve had moderate to severe heart failure. People with heart failure often are anemic and face extreme exhaustion during exercise. The authors of the study said that Epo may help reduce exhaustion by increasing oxygen delivery to the tissues.

The efficacy of Epo in exercise was studied on normal people and athletes where Epo was associated with increased exercise capacity.

Another study says that Epo corrects anemia. The hormone is also said to reduce the extent of concussion in people who have had recent brain injury.

Experts say that an average person can prevent diabetes type-2, heart diseases, stroke and various other complications just by adopting a more active lifestyle. 30 minutes of physical activity per day for about 5 days a week is recommended for most people.

“If you can’t put exercise in a pill, then maybe you can put the motivation to exercise in a pill instead. As more and more people become overweight and obese, we must attack the problem from all angles. Maybe the day will come when gyms are as easily found as fast food restaurants,” said Dr. Gerald Weissmann, editor-in-chief of The FASEB Journal. 

Published by Medicaldaily.com

Pill to Increase Motivation to Exercise

San Diego, California News Station – KFMB Channel 8 – cbs8.comJ&J to stop selling pelvic mesh tied to lawsuits

By MATTHEW PERRONEAP Health Writer

WASHINGTON (AP) – Johnson & Johnson plans to stop selling surgical mesh implants used to treat women's health problems, which have been linked to injuries and triggered hundreds of lawsuits.

The company sent a letter Monday to judges in new Jersey and West Virginia who are overseeing patient lawsuits against the company. J&J said it plans to phase out four mesh products over the next three to nine months.

The plastic mesh is used to strengthen the pelvic wall in cases of pelvic organ prolapse, in which the bladder or other reproductive organs slip down into the vagina. About 75,000 women had prolapse surgery with mesh inserted through the vagina last year. a similar procedure using an incision in the abdomen is less common.

J&J said the mesh products are safe and that it is not recalling them.

“Our decision to discontinue these products is based on their commercial viability in light of changing market dynamics, and is not related to safety or efficacy,” the new Brunswick, N.J., company said in a statement.

But the Food and Drug Administration reported last year that the implants were associated with higher rates of pain, bleeding and infection than traditional surgery with stitches. The agency said 10 percent of women experienced erosion or exposure of the mesh within 12 months of having the mesh implanted. more than half of these women required follow-up surgery to remove the mesh. Some required two or three surgeries.

At the same time, the FDA said it saw no evidence that using mesh led to better outcomes than traditional surgery with stitches.

In January, the FDA ordered J&J and five other companies to conduct rigorous studies to track the complication rates with their products over time. J&J said in its letter it expects the FDA to waive that requirement once it phases out the products.

Consumer safety advocates hailed the announcement as a victory.

“These companies know they will never be able to prove safety and efficacy of these devices in the studies mandated by the FDA in January of this year,” said Lana Keeton, a Miami resident who has undergone 17 surgeries to remove mesh that was implanted in 2001. Keeton's group, Truth in Medicine, has lobbied the FDA on the risks of mesh in recent years.

Mesh products initially were seen as a high-tech improvement over traditional surgery, which also can have complications. since similar mesh was already used in other types of surgery, the products received fast-track approval from the FDA without the tests that the agency requires for first-of-a-kind devices.

In its last quarterly filing with regulators, J&J said the “number of pending product liability lawsuits continues to increase,” and that it has set aside money to pay for litigation costs associated with the mesh, though it didn't specify an amount.

Federal cases against the company have been consolidated in the Southern District of West Virginia. The state cases in new Jersey have been centralized in a state court in Atlantic County.

Other manufacturers of pelvic mesh include Boston Scientific Corp., Covidien plc, CR Bard Inc. and American Medical Systems.

Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

San Diego, California News Station – KFMB Channel 8 – cbs8.comJ&J to stop selling pelvic mesh tied to lawsuits

Highly targeted irradiation as good as whole breast radiotherapy in early stage cancer

[ back to EurekAlert! ]Public release date: 11-May-2012 [ | E-mail | Share Share ] Contact: Mary Ricemary.rice@riceconseil.eu European Society for Radiotherapy and Oncology (ESTRO)

Barcelona, Spain: using a concentrated, highly targeted dose of radiation to the breast has equally good results as irradiating the whole area, with no adverse effects on survival and a much better cosmetic outcome, Hungarian researchers have found. Reporting the ten-year results of a randomised trial, Professor Csaba Polg

Obagi® Medical Products Presents Study Results at American Academy of Dermatology

LONG BEACH, Calif., Mar 20, 2012 (BUSINESS WIRE) –Obagi Medical Products, inc. /quotes/zigman/102957/quotes/nls/ompi OMPI +0.39% , a leader in topical aesthetic and therapeutic skin health systems, released the results of three new studies this weekend at the American Academy of Dermatology meeting in San Diego, CA. the studies explored the use of the Nu-Derm system with tretinoin, as prescribed by the investigators, in the treatment of melasma and hyperpigmentation in patients with Fitzpatrick skin types III — VI. each study evaluated the efficacy and tolerability of the treatment on the skin as well as its effects on the patients’ emotional well-being.

“Nu-Derm with tretinoin has long been a go-to regimen, particularly in difficult-to-treat melasma, for many dermatologists,” Jim Hartman, Vice President Global Marketing and Business Development at Obagi, said. “Our objective in partnering with these respected experts in the field of dermatology for these studies was to provide clinical proof that Nu-Derm, in combination with varying percentages of tretinoin, based on recommendations from key opinion leaders, is a valid, effective option in many skin types, including darker skin patients, as well as in patients more sensitive to irritation. the results presented this weekend indicate that we successfully met that objective.”

the 75 patients in the three studies followed a morning regimen that included a foaming gel cleanser, toner, four percent hydroquinone product, exfoliation enhancer and a sunscreen with SPF 35. the evening regimen consisted of a foaming gel cleanser, toner and four percent hydroquinone product mixed with a tretinoin cream at various percentages. Patients reported high levels of patient satisfaction and improved quality of life metrics across the studies.

the studies postered and affiliated investigators are as follows:

Study 4581 – Treatment of Moderate or marked Melasma in Darker Skin with a Four Percent Hydroquinone Skin Care system Plus 0.025% Tretinoin Cream:

— Lead investigator for Study 4581 is Pearl Grimes, MD (Los Angeles, CA)

Study 5131 – Treatment of Moderate or marked Melasma with a Four Percent Hydroquinone Skin Care system Plus 0.1 Percent Tretinoin Cream: Comparison in Asian and Caucasian Patients:

— Lead investigator for Study 5131 is Dr. Suzanne Bruce (Suzanne Bruce & Associates, PA; Houston, TX)

Study 5139 – Treatment of Moderate or marked Melasma in Darker Skin with a Four Percent Hydroquinone Skin Care system Plus 0.05% Tretinoin Cream:

— Lead investigators for Study 5139 are Michael Gold, MD (Nashville, TN), Marta Rendon, MD (Boca Raton, FL), Barry DiBernardo, MD (Monclair, NJ), Suzanne Bruce (Suzanne Bruce & Associates, PA; Houston, TX) and Chere Lucas-Anthony, MD (Boca Raton, FL)

the investigators reported considerable improvements in melasma and skin discoloration, in addition to high levels of patient satisfaction across all three studies.

this same regimen administered through the studies is available via participating dermatologists and physicians that prescribe or sell the Obagi Nu-Derm system, which includes a cleanser, toner, exfoliation enhancer (Exfoderm and Exfoderm Forte), four percent hydroquinone product (Nu-Derm Clear and Nu-Derm Blender), Sunscreen SPF 35 (Healthy Skin Protection SPF 35) and, if recommended by the prescribing physician, tretinoin cream.

Obagi Medical Products are available for purchase in dermatology, plastic surgery and other aesthetic physicians’ practices.

ABOUT OBAGI MEDICAL PRODUCTS, INC.

Obagi Medical Products is a specialty pharmaceutical company that develops, markets and sells, and is a leading provider of, proprietary topical aesthetic and therapeutic prescription-strength skin care systems in the physician-dispensed market. Using its Penetrating Therapeutics™ technologies, Obagi Medical’s products are designed to improve penetration of agents across the skin barrier for common and visible skin conditions in adult skin including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, rosacea, and soft tissue deficits, such as fine lines and wrinkles. Obagi Medical’s portfolio, which includes cosmetic, over-the-counter and prescription products, including 4% hydroquinone, is sold and promoted only through physician offices and requires education by a physician on proper use. the history of Obagi’s skin care product introductions is as follows: Obagi Nu-Derm®, Obagi-C® Rx (a prescription-strength vitamin C and hydroquinone system), Obagi® Professional-C (a line of highly stable vitamin C serums), Obagi Condition &Enhance® for use with cosmetic procedures to enhance patient outcomes and satisfaction, Obagi ELASTIderm® Eye Treatment and Obagi CLENZIderm® M.D. acne therapeutic systems, a formulation of Obagi CLENZIderm M.D. Systems for normal to dry skin, and Obagi ELASTIderm Décolletage system, Obagi Rosaclear® system, Obagi ELASTILash® Eyelash Solution, Obagi Blue Peel RADIANCE®, and Nu-Derm® Sun Shield SPF 50. Visit http://www.obagi.com for information.

Penetrating Therapeutics is a trademark, and Obagi, the Obagi logo, Blue Peel RADIANCE, Condition & Enhance, ELASTIderm, ELASTILash, Nu-Derm, Obagi-C, Obagi CLENZIderm and Rosaclear are registered trademarks, of Obagi Medical Products, inc. and/or its affiliates in the United States and certain other countries.

SOURCE: Obagi Medical Products, inc.

Creative Media Marketing Martha Miller, 212-979-8884 Martha@cmmpr.com

Copyright Business Wire 2012

Obagi® Medical Products Presents Study Results at American Academy of Dermatology

Blepharoplasty Preparation – Before and After

Eyelid surgery or the Blepharoplasty surgery is a way to reduce the effect of the droopy eyelids and make sure that you get a youthful look. That said there are a couple of things that you should do before the surgery and a few things after the surgery.

Before you go in for the surgery make sure that you have done adequate research on the surgeon’s credentials. Your look post surgery really depends on the efficacy of the surgeon and in case the surgeon is not capable enough then you will have very depressing experience. the other thing that you need to do is to tie up the finances. you can get financing easily if you so wish as there are a lot of specialized financing companies available who will be able to loan you the money.

After the surgery the major challenge is the rest. you should be avoiding having to watch the television and make sure that you rest your eyes for at least two three days. That will help heal the sutures fast and also will make sure that you are able to join back to work fast. Also in case you feel the pain then go straight to the surgeon rather than waiting as there may be some complications which the surgeon only can take care of.

Another important thing to do after the surgery is to make sure that you have the best cream applied on the sutures to let them heal. there are special creams available for application on stitches.

Blepharoplasty Preparation – Before and After

Imagine A Face Lift Cream That Can Give You a Cosmetic Surgery Result Without The Pain And Expense

Wouldn’t it be wonderful if you could find a truly effective facelift cream? Just simply apply it to your face and watch wrinkles, lines and sagging skin disappear to be replaced with firm smooth even-toned skin. is it possible?

With the advancement of modern day science and technology face lift creams have certainly evolved and new possibilities have been discovered, thanks to dedicated researchers and many human volunteers who were willing to try products new on the market to ensure their efficacy.

If you have watched your face age over the years and has tried many of the so-called facelift products on the market without any positive results. I am glad you found this article. Particularly if you have been scared to go under the knife because of all the negative publicity of plastic surgery and the uncertainty of the end result. I know exactly how you feel.

However thanks to the discovery of specially formulated natural firming substance you can now rest assured that you will not have to even concern yourself about cosmetic surgery or other invasive procedures.

First of all you need to address the major causes of aging which are:

1. Loss of collagen and elastin 2. lower level of hyaluronic acid 3. Oxidation caused by free radical activities.

These are the three main causes of aging. a face lift cream that can counter all three causes will lead to younger, firmer face.

How do you go about fighting these causes of aging? find a product that contains special ingredients made to counter these issues and reverse the signs of aging.

One of the major reasons your face age and sag is the loss of collagen and elastin. if you can naturally rebuild these two vital proteins then you will notice a big improvement in your facial skin. one substance that has been effectively lifting facial skin because of its ability to stimulate the natural production of collagen and elastin is Cynergy TK. Proven effective and have been helping lots of men and women alike shed years off their face.

Other natural active ingredients used along with Cynergy TK are Phytessence Wakame and COQ10. These help with rebuilding hyaluronic acid level and fight free radicals because of their high antioxidant properties.

There is no need to even consider cosmetic surgery when there are natural face lift creams that will get the job done and give you firm, toned wrinkle free skin.

Imagine A Face Lift Cream That Can Give You a Cosmetic Surgery Result Without The Pain And Expense

Prescription for a Day at the Spa

Boston, MA (PRWEB) May 06, 2011

Many plastic surgeons are incorporating skin care services into their patient treatment plans. A panel at the Annual Meeting of the American Society for Aesthetic Plastic Surgery (ASAPS) will explore the role of medical grade, topical skincare treatments for facial rejuvenation and update plastic surgeons on the efficacy of these treatments. “Skin Care – Lotions & Potions for Wrinkles: What really Works?,” will be moderated by Clifford P. Clark, III, MD, and feature panelists Jeff Dover, MD , Renato Saltz, MD, and Victoria Vitale-Lewis, MD.

“This panel will update surgeons on the most successful skin care treatments,” said moderator Clifford P. Clark, III, MD. “The speakers will emphasize evidence-based medicine and attempt to separate science from hype. We will also construct an algorithm for treating photo-aging according to various skin types.”

Non-surgical skincare treatments, such as topical wrinkle treatments and chemical peels, can be used in conjunction with plastic surgery to enhance outcomes and help patients maintain the results of their procedures.

“Skin is a living organ and is constantly changing,” said Dr. Saltz. “For the best surgical results, it is important to think about the quality of the skin and what we can do to improve it, which may mean incorporating skincare techniques into our practice.”

“Medical grade skin care can be as important to the patient as plastic surgery itself,” added Dr. Vitale-Lewis. “Recent research breakthroughs mean there is a very exciting future for skin care.”

Over 7.7 million nonsurgical cosmetic procedures were performed in 2010 and $1.9 billion spent on skin rejuvenation treatments, according to ASAPS. currently, over 20% of plastic surgeons offer spa services or work in conjunction with medical spas where nonsurgical procedures are performed.

Skin Care – Lotions and Potions for Wrinkles –What really Works? Tuesday, May 10th, 7:45am Moderator:     Clifford P. Clark, III, MD Panelists:      Jeff Dover, MD Renato Saltz, MD Victoria Vitale-Lewis, MD

PRESENTERS are available for interviews. CONTACT THE ASAPS COMMUNICATIONS STAFF.

About ASAPS The American Society for Aesthetic Plastic Surgery (ASAPS), is recognized as the world’s leading organization devoted entirely to aesthetic plastic surgery and cosmetic medicine of the face and body. ASAPS is comprised of over 2,600 Plastic Surgeons; active members are certified by the American Board of Plastic Surgery (USA) or by the Royal College of Physicians and Surgeons of Canada and have extensive training in the complete spectrum of surgical and non-surgical aesthetic procedures. International active members are certified by equivalent boards of their respective countries. All members worldwide adhere to a strict Code of Ethics and must meet stringent membership requirements.

Website: http://www.surgery.org Follow ASAPS on Twitter: http://www.twitter.com/ASAPS Become a fan of ASAPS on Facebook: http://www.facebook.com/AestheticSociety Become a member of Project Beauty: http://www.projectbeauty.com Locate a plastic surgeon in your area: http://www.surgery.org/consumers/find-a-plastic-surgeon

Contact: Adeena Babbitt or Ashley Barton: (212) 921-0500, media(at)surgery(dot)org Annual Meeting press office open: May 7-11: Phone: 617-954-3452

Read the full story at http://www.prweb.com/releases/ASAPS/skin-care/prweb8383020.htm

<a href="http://www.digitaljournal.com/pr/300468tag:news.google.com,2005:cluster=http://www.digitaljournal.com/pr/300468Fri, 06 May 2011 13:12:27 GMT 00:00″>Prescription for a Day at the Spa

KYTHERA Biopharmaceuticals Announces Positive Results from Phase IIb Study with ATX-101 Demonstrating Reduction of Submental Fat – News Press Release

KYTHERA Biopharmaceuticals, inc. (“KYTHERA”) today announced that it has successfully completed a third Phase II clinical study with ATX-101, a first-in-class adipolytic agent that is under investigation for the reduction of submental (‘under-the-chin’) fat. the Phase IIb, randomized, double-blind, placebo-controlled, dose-ranging study showed ATX-101 was well tolerated and demonstrated statistically significant efficacy as compared with placebo. the study enrolled a total of 129 subjects and was conducted across 10 dermatology and plastic surgery centers in the United States. Multiple clinician and patient endpoints were assessed, as well as MRI to objectively quantify fat reduction. the study tested two drug-dosing regimens (1 and 2 mg/cm2).

in this study, ATX-101 demonstrated statistically significant (p<0.05) reductions in submental fat as compared with placebo as assessed by all measures: a validated clinician scale, patient reported outcome (PRO) scale, and Magnetic Resonance Imaging (MRI) measurement for both fat volume and thickness. Adverse events were primarily mild to moderate, and were transient. in addition, a statistically significant difference versus placebo was also shown on other PRO measures, including instruments measuring subject satisfaction, patient impact and chin attractiveness.

“An injectable treatment, with promising results in the reduction of submental fat, expands options for aesthetic patients seeking minimally invasive treatment,” said V. Leroy Young, MD, FACS, a plastic surgeon in private practice in St. Louis and an investigator in the study. “Reductions of fat in a targeted area such as the chin can have substantial impact on both appearance and patient satisfaction, and this is borne out in the photographic and MRI assessments in the Phase IIb data.”

“We are very pleased with the results and the meaningful improvements the subjects achieved. This is truly a breakthrough for aesthetic medicine, bringing together clinician and patient reported outcomes on validated scales, along with an objective and quantifiable endpoint,” said Patricia Walker, MD, PhD, KYTHERA’s Chief Medical Officer. “We look forward to presenting the data at an upcoming scientific meeting.”

KYTHERA has done extensive development work on ATX-101 for submental fat and has completed seven clinical trials and treated more than 350 subjects. in two previously conducted ex-US Phase II studies on 155 patients, ATX-101 was well-tolerated and yielded statistically significant reduction of submental fat compared to placebo based on clinician and patient assessments. Results observed from the current Phase IIb study confirmed the observations made in previous Phase II clinical trials. Phase III studies of ATX-101 were initiated in late 2010 in Europe in collaboration with Bayer HealthCare’s dermatology unit Intendis, which has licensed rights to ATX-101 outside of the U.S. and Canada.

“These results are exciting,” said Gary Monheit, MD, a dermatologist in private practice in Alabama and an investigator in this study. “ATX-101 has the potential to expand facial rejuvenation for aesthetic patients, filling an existing gap for minimally invasive submental fat reduction.”

ATX-101 is a first-in-class injectable drug being studied for the reduction of small volumes of fat, including submental fat. it is based on an endogenous molecule with unique features including selectivity for adipocytes and rapid clearance. This minimally invasive procedure, done with little or no anesthetic, has the promise to yield consistent and meaningful clinical results. Clinical studies to date have demonstrated that ATX-101 is well-tolerated and may effectively reduce localized fat in the submental area. three randomized, double-blind, placebo-controlled, Phase II studies with ATX-101 in the reduction of submental fat and four Phase I pharmacokinetic, histology, lipid and tolerability studies have been successfully completed.

About Submental fat (SMF)

Submental fat is localized subcutaneous fat located immediately beneath the chin and jawline. in the rapidly growing market of minimally invasive, non-surgical facial rejuvenation, the reduction of facial fat to restore and reshape the jawline remains one of the largest unmet patient needs. according to a recent national, multi-center, clinical evaluation of more than 385 BOTOX® and dermal filler patients, 78% of patients had a measurable excess of submental fat. Currently, there are no FDA approved drugs to reduce excess localized fat.

About KYTHERA Biopharmaceuticals, inc.

KYTHERA Biopharmaceuticals, inc. is a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic market. KYTHERA has an innovative pipeline, with its lead program in adipolysis (ATX-101) projected to start US Phase III trials in 2011. the company also has active research programs in hair and fat biology, pigmentation modulation and facial contouring. find more information at www.kytherabiopharma.com.

Business Wirehttp://www.businesswire.com/

Last updated on: 04/02/2011 12:00:12

KYTHERA Biopharmaceuticals Announces Positive Results from Phase IIb Study with ATX-101 Demonstrating Reduction of Submental Fat – News Press Release

Laser Hair Removal

Epilation by laser was performed experimentally for about 20 years before it became commercially available in the mid 1970s. Intense Pulsed Light (IPL) epilators, though technically not a laser, use xenon flash lamps that emit full spectrum light. Laser and light-based methods, sometimes called phototricholysis or photoepilation, are now most commonly referred to collectively as “laser hair removal”. one of the first published articles describing laser hair removal was authored by the group at Massachusetts General Hospital in 1998.

The efficacy of laser hair removal is now generally accepted in the dermatology community, and laser hair removal is widely practiced. Many reviews of laser hair removal methods, safety, and efficacy have been published in the dermatology literature

Laser hair removal is accomplished in a series of sessions generally done monthly or every other month. The average number of sessions to achieve over 80 percent permanent hair reduction in 80-90 percent of good candidates is approximately 4 to 7 sessions.

In between these monthly sessions some of the hair will regrow as hairs cycle. Hairs that may have been dormant during your previous laser hair removal session may now be in the growth phase. this is where the need for multiple treatment sessions arises. Multiple sessions ensures that all the hairs are subjected to the treatment. these hairs may be shaved by the patient between sessions if desired.some normal side effects may occur after laser hair removal treatments, including itching, redness and swelling around the treatment area. these side effects should not last more than three days. some level of pain should also be expected during treatments. Numbing creams are available at most clinics, usually for an additional cost. Icing the area after the treatment helps relieve the side effects faster.

Unwanted side effects such as hypo- or hyper-pigmentation or, in extreme cases, burning of the skin call for an adjustment in laser settings. Risks include the chance of burning the skin  or discoloration of the skin, hypopigmentation (white spots), flare of acne, swelling around the follicle, scab forming, purpura, and infection. these risks can be avoided when being treated at with an appropriate laser type and at appropriate settings for the individual’s skin type.

Some patients may show side effects from an allergy to either the hair removal gel used with certain laser types or to a numbing cream. a physician should be consulted if an allergic reaction presents itself after the treatment.

this entry was posted on Monday, July 5th, 2010 at 4:42 pm and is filed under Uncategorized. you can follow any responses to this entry through the RSS 2.0 feed. you can leave a response, or trackback from your own site.

Laser Hair Removal